Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp.

Autor: Rodrigues M; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Ramtohul T; Department of Radiology, Institut Curie, PSL Research University, Paris, France., Rampanou A; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France., Sandoval JL; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France., Houy A; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Servois V; Department of Radiology, Institut Curie, PSL Research University, Paris, France., Mailly-Giacchetti L; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Pierron G; Somatic Genetic Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France., Vincent-Salomon A; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Cassoux N; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France., Mariani P; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France., Dutriaux C; Dermatology Department, Hôpital Saint André Centre Hospitalier Universitaire, Bordeaux, France., Pracht M; Medical Oncology Department, Centre Eugène Marquis, Rennes, France., Ryckewaert T; Medical Oncology Department, Oscar Lambret Center, Lille, France., Kurtz JE; Department of Medical and Surgical Oncology & Hematology, ICANS, Strasbourg, France., Roman-Roman S; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France.; Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France., Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France.; UVSQ, Paris-Saclay University, Saint Cloud, France., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France. marc-henri.stern@curie.fr., Renault S; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France. shufang.renault@curie.fr.

Publikováno v: Nature communications [Nat Commun] 2024 Oct 14; Vol. 15 (1), pp. 8851. Date of Electronic Publication: 2024 Oct 14.

Institut Curie guidelines on breast target volume delineation for patients treated in lateral position

Autor: Msika, R., Fourquet, A., Laki, F., Porte, B., Servois, V., Kirova, Y. ^*

Publikováno v: In Cancer / Radiothérapie December 2020 24(8):795-798

Novel patterns of response under immunotherapy

Autor: Borcoman, E., Kanjanapan, Y., Champiat, S., Kato, S., Servois, V., Kurzrock, R., Goel, S., Bedard, P., Le Tourneau, C. ^*

Publikováno v: In Annals of Oncology March 2019 30(3):385-396

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Autor: Saâda-Bouzid, E., Defaucheux, C., Karabajakian, A., Coloma, V.P., Servois, V., Paoletti, X., Even, C., Fayette, J., Guigay, J., Loirat, D., Peyrade, F., Alt, M., Gal, J., Le Tourneau, C. ^*

Publikováno v: In Annals of Oncology July 2017 28(7):1605-1611

Tumor Growth Rate as a Predictive Marker for Recurrence and Survival After Liver Resection in Patients with Liver Metastases of Uveal Melanoma.

Autor: Ramtohul T; Department of Radiology, Institut Curie, Paris, PSL Research University, Paris, France. toulsie.ramtohul@curie.fr.; INSERM U1288, Laboratoire d'Imagerie Translationnelle en Oncologie, PSL Research University, 91400, Orsay, France. toulsie.ramtohul@curie.fr., Abdul-Baki M; Department of Radiology, Institut Curie, Paris, PSL Research University, Paris, France., Rodrigues M; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.; INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Paris, France., Cassoux N; Department of Ocular Oncology, Institut Curie, PSL Research University, Paris, France.; UMR 144 CNRS, Université de Paris, Paris, France., Gardrat S; INSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Paris, France.; Department of Biopathology, Institut Curie, PSL Research University, Paris, France., Ait Rais K; Somatic Genetic Unit, Department of Genetics, Institut Curie, PSL University, Paris, France., Pierron G; Somatic Genetic Unit, Department of Genetics, Institut Curie, PSL University, Paris, France., Bouhadiba T; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France., Servois V; Department of Radiology, Institut Curie, Paris, PSL Research University, Paris, France. vincent.servois@curie.fr.; INSERM U1288, Laboratoire d'Imagerie Translationnelle en Oncologie, PSL Research University, 91400, Orsay, France. vincent.servois@curie.fr., Mariani P; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8480-8491. Date of Electronic Publication: 2022 Aug 18.